Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RHOST: Reactive Household Treatment for Malaria
NCT02878200Completed
- Sponsor
- London School of Hygiene & Tropical Medicine
- Start
- Nov 2016
- Primary completion
- Dec 2018
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of dihydroartemisinin and piperaquine in malaria (2 arms), sponsored by London School of Hygiene & Tropical Medicine. Primary endpoint: prevalence of malaria infection at 24 months. Started Nov 2016; status: completed.
02
Drugs
dihydroartemisininpiperaquine
03
Conditions
malaria
Beyond the preview
Go deeper on NCT02878200.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02878200.